ACSS2 and inflammatory bowel disease: Immunohistochemistry results unveiled a remarkable reduction of ACSS2 and Pan‐Kcr protein levels in IBD patients (Figure 1G,H), which was negatively associated with disease severity (Figure S1F–I, Supporting Information).